Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:57 pm Purchase | 2021-12-31 | 13G | eHealth, Inc. EHTH | Palo Alto Investors LP | 1,615,570 6.120% | 1,615,570![]() (New Position) | Filing History |
| 2021-02-16 4:49 pm Sale | 2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Palo Alto Investors LP | 4,230,548 7.740% | -294,928![]() (-6.52%) | Filing History |
| 2021-02-16 4:44 pm Sale | 2020-12-31 | 13G | STAAR Surgical Company STAA | Palo Alto Investors LP | 2,849,348 6.180% | -929,590![]() (-24.60%) | Filing History |
| 2021-02-16 4:41 pm Purchase | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 351,177 7.160% | 44,843![]() (+14.64%) | Filing History |
| 2021-02-16 4:38 pm Sale | 2020-12-31 | 13G | Insmed Incorporated INSM | Palo Alto Investors LP | 6,105,980 5.990% | -742,780![]() (-10.85%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 6,738,913 6.630% | 592,968![]() (+9.65%) | Filing History |
| 2021-02-16 4:29 pm Sale | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | Palo Alto Investors LP | 4,469,411 5.060% | -586,875![]() (-11.61%) | Filing History |
| 2021-02-16 4:24 pm Sale | 2020-12-31 | 13G | AMAG PHARMACEUTICALS INC AMAG | Palo Alto Investors LP | 0 0.000% | -3,045,065![]() (Position Closed) | Filing History |
| 2021-02-16 4:20 pm Purchase | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | Palo Alto Investors LP | 802,423 15.640% | 802,423![]() (New Position) | Filing History |
| 2021-02-16 4:14 pm Sale | 2020-12-31 | 13G | AIMMUNE THERAPEUTICS INC AIMT | Palo Alto Investors LP | 0 0.000% | -3,380,441![]() (Position Closed) | Filing History |

